Organogenesis Inc.

NASDAQ: ORGO · Real-Time Price · USD
4.72
0.02 (0.43%)
At close: Aug 15, 2025, 3:59 PM
4.80
1.59%
After-hours: Aug 15, 2025, 05:16 PM EDT

Organogenesis Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
101M 86.69M 126.66M 115.18M 130.23M 109.98M 99.65M 108.53M 117.32M 107.64M 115.52M 116.86M 121.4M 98.12M 128.56M 113.75M 123.2M 102.55M
Cost of Revenue
34.28M 23.72M 31.05M 26.8M 25.54M 32.36M 31.87M 25.79M 26.32M 26.61M 27.11M 26.18M 26.65M 25.08M 32.6M 26.17M 29.94M 25.5M
Gross Profit
66.72M 62.97M 95.61M 88.38M 104.7M 77.62M 67.78M 82.74M 91M 81.03M 88.41M 90.68M 94.75M 73.04M 95.96M 87.59M 93.26M 77.06M
Operating Income
-12.58M -26.75M 10.22M 6.24M -13.89M -3.85M 649K 8.05M 9.74M -3.98M 4.16M 1.78M 11.94M 872K 20.45M 16.26M 23.59M 12.62M
Interest Income
n/a 961K n/a n/a n/a n/a n/a n/a 594K 649K 30K 572K n/a n/a n/a n/a n/a n/a
Pretax Income
-11.83M -25.78M 10.25M 5.82M -14.54M -4.34M -1.8M 7.64M 9.18M -4.63M 8.75M 1.21M 11.18M 132K 19.59M 12.88M 21.17M 10.14M
Net Income
-9.39M -21.59M 7.67M 12.33M -17.04M -2.1M -568K 3.17M 5.32M -2.97M 7.49M 215K 8.74M 87K 51.7M 12.58M 20.69M 9.94M
Selling & General & Admin
73.81M 72.51M 73.86M 71.8M 76.54M 72.32M 61.38M 64.22M 70.32M 73.83M 68.29M 79.33M 72.61M 63.58M 67.25M 62.37M 62.35M 58.23M
Research & Development
10.39M 10.64M 11.53M 10.34M 15.59M 12.81M 11.77M 10.47M 10.94M 11.2M 11.39M 9.57M 10.21M 8.59M 8.26M 8.95M 7.32M 6.21M
Other Expenses
-6.87M n/a n/a n/a -4.41M n/a -6.02M n/a 28K 23K 6K 5K -21K -3K -9K -19K 18K -3K
Operating Expenses
77.33M 83.15M 85.39M 82.14M 87.72M 85.13M 67.13M 74.69M 81.25M 85.04M 79.69M 88.9M 82.81M 72.17M 75.51M 71.32M 69.67M 64.44M
Interest Expense
669K n/a -61K 471K 620K 514K 502K 444K 594K 649K n/a 572K 730K 737K 853K 1.48M 2.43M 2.47M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 5.22M n/a n/a n/a 4.81M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
111.62M 106.87M 116.44M 108.94M 121.33M 113.83M 100.92M 100.48M 107.57M 111.64M 106.8M 115.08M 109.47M 97.25M 108.11M 97.49M 99.61M 89.94M
Income Tax Expense
-2.44M -6.94M 2.58M -6.51M 2.5M -2.24M -1.23M -4.47M 3.86M -1.66M 1.27M 997K 2.44M 45K -32.11M 303K 487K 200K
Shares Outstanding (Basic)
126.85M 126.3M 131.67M 132.58M 132.57M 131.86M 130.92M 131.31M 131.29M 131.08M 130.92M 130.9M 129.64M 128.79M 128.66M 128.55M 128.24M 127.87M
Shares Outstanding (Diluted)
126.85M 126.3M 132.16M 133.93M 132.57M 131.86M 131.86M 133.42M 133.07M 131.08M 131.86M 132.23M 132.6M 132.81M 133.35M 133.85M 133.99M 133.45M
EPS (Basic)
-0.1 -0.17 0.06 0.09 -0.13 -0.02 -0.00 0.02 0.04 -0.02 0.06 0.00 0.07 0.00 0.40 0.10 0.16 0.08
EPS (Diluted)
-0.1 -0.17 0.06 0.09 -0.13 -0.02 -0.00 0.02 0.04 -0.02 0.06 0.00 0.07 0.00 0.39 0.09 0.15 0.07
EBITDA
-12.58M -26.75M 14.64M 10.7M -9.72M 4.57M 5.04M 13.93M 15.18M 1.89M 13.31M 6.29M 16.46M 2.44M 25.27M 19.09M 27.34M 15.99M
EBIT
-11.83M -25.78M 10.19M 6.29M -13.92M -3.83M -1.29M 8.08M 9.77M -3.98M 8.72M 1.78M 11.91M 869K 20.44M 14.36M 23.61M 12.61M
Depreciation & Amortization
n/a 4.29M 4.45M 4.4M 4.2M 8.39M 6.33M 5.84M 5.41M 5.86M 4.55M 4.51M 4.55M 4.42M 4.82M 4.73M 3.74M 3.38M